These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 34157326

  • 41. Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways.
    Chen JY, Yang YJ, Meng XY, Lin RH, Tian XY, Zhang Y, Lai WF, Yang C, Ma XQ, Huang MQ.
    Phytomedicine; 2024 Sep; 132():155585. PubMed ID: 39068811
    [Abstract] [Full Text] [Related]

  • 42. Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.
    Li N, Feng F, Wu K, Zhang H, Zhang W, Wang W.
    Biomed Pharmacother; 2019 Nov; 119():109387. PubMed ID: 31487583
    [Abstract] [Full Text] [Related]

  • 43. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro.
    Dong H, Guo H, Liang Y, Wang X, Niu Y.
    Free Radic Res; 2017 Feb; 51(2):167-178. PubMed ID: 28147890
    [Abstract] [Full Text] [Related]

  • 44. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C, Chen W, Ding H, Li D, Wen G, Zhang C, Lu W, Chen M, Yang Y.
    Life Sci; 2019 Dec 15; 239():116881. PubMed ID: 31678285
    [Abstract] [Full Text] [Related]

  • 45. Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions.
    Yoshida K, Murata M, Yamaguchi T, Matsuzaki K, Okazaki K.
    J Clin Med; 2016 Jan 12; 5(1):. PubMed ID: 26771649
    [Abstract] [Full Text] [Related]

  • 46. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 12; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

  • 47. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways.
    Chen Q, Zhang H, Cao Y, Li Y, Sun S, Zhang J, Zhang G.
    Drug Des Devel Ther; 2017 Feb 12; 11():2179-2191. PubMed ID: 28794616
    [Abstract] [Full Text] [Related]

  • 48. Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients.
    Nakamura N, Yoshida K, Tsuda R, Murata M, Yamaguchi T, Suwa K, Ichimura M, Tsuneyama K, Matsuzaki K, Nakano T, Hirohara J, Seki T, Okazaki K, Gershwin ME, Naganuma M.
    Front Biosci (Landmark Ed); 2021 Dec 30; 26(12):1480-1492. PubMed ID: 34994163
    [Abstract] [Full Text] [Related]

  • 49. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ, Kim JY, Min AK, Park KG, Harris RA, Kim HJ, Lee IK.
    Free Radic Biol Med; 2012 Feb 01; 52(3):671-682. PubMed ID: 22155056
    [Abstract] [Full Text] [Related]

  • 50. Astragaloside IV Induces Apoptosis, G1-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma.
    Su CM, Wang HC, Hsu FT, Lu CH, Lai CK, Chung JG, Kuo YC.
    In Vivo; 2020 Feb 01; 34(2):631-638. PubMed ID: 32111763
    [Abstract] [Full Text] [Related]

  • 51. Metformin mitigates carbon tetrachloride-induced TGF-β1/Smad3 signaling and liver fibrosis in mice.
    Fan K, Wu K, Lin L, Ge P, Dai J, He X, Hu K, Zhang L.
    Biomed Pharmacother; 2017 Jun 01; 90():421-426. PubMed ID: 28390311
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
    Wang YN, Zhao SL, Su YY, Feng JX, Wang S, Liao XM, Wang LN, Li JC, Meng P, Li HY, Zhang YF.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32515466
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q, Zhang X, Bai F, Nie J, Wen S, Wei Y, Wei J, Huang R, He M, Lu Z, Lin X.
    Int Immunopharmacol; 2019 Jan 26; 66():41-51. PubMed ID: 30419452
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.
    Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K.
    Cancers (Basel); 2018 Jun 05; 10(6):. PubMed ID: 29874844
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.